Beaconcure Inc., a leader in AI-driven clinical data validation, and Phastar Inc., a biometrics CRO, have partnered to streamline clinical trial processes. This collaboration leverages Beaconcure’s technology and Phastar’s expertise to improve data accuracy and accelerate drug development.

Beaconcure’s Verify platform integrates with Phastar’s operations, reducing human error and streamlining workflows. Teams can collaborate effectively, ensuring data consistency and expediting decision-making. This enhances internal communication and sponsor interactions.

Phastar prioritizes patient needs and embraces innovative solutions. Implementing Verify aims to improve clinical data reporting, review, and submission processes. Automated audit trails, efficient data delivery, and optimized workflow management facilitate more efficient clinical review.

Beaconcure and Phastar are dedicated to advancing clinical research. The partnership explores new industry standards to enhance speed and compliance in clinical trials. They believe this collaboration will lead to innovative systems continuously learning and optimizing processes.

Beaconcure and Phastar empower researchers to develop lifesaving treatments more rapidly and effectively. By integrating technological advancements into clinical trials, they are transforming the healthcare landscape for patients in urgent need.

Source link: http://www.businesswire.com/news/home/20240520818825/en/Phastar-and-Beaconcure-Announce-Partnership-to-Deliver-Process-Revolution-in-Clinical-Data-Review

+ posts

Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.